Relay Therapeutics (RLAY)

• Market cap: $1.47B
• 1 day: 5.6%
• 5 days: 9%
• 1 month: 28.1%
• 3 months: 108.87%
• 6 months: 159.33%
• Year to date: 97.21%
• 1 year: 75.21%
• 5 years: -81.45%
• 10 years: -75.81%
• Sector: Healthcare
• Industry: Biotechnology

About: Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Employees: 197